"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.
Publication
, Journal Article
Fatola, O; Corneli, A; Perry, B; Hanlen-Rosado, E; Nsonwu, A; Constantine, EP; Thompson, AB
Published in: J Pediatric Infect Dis Soc
May 30, 2022
Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
May 30, 2022
Volume
11
Issue
5
Start / End Page
221 / 224
Location
England
Related Subject Headings
- United States
- Humans
- Health Knowledge, Attitudes, Practice
- HIV Infections
- Child
- Adolescent
- AIDS Vaccines
- 3213 Paediatrics
- 3207 Medical microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fatola, O., Corneli, A., Perry, B., Hanlen-Rosado, E., Nsonwu, A., Constantine, E. P., & Thompson, A. B. (2022). "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc, 11(5), 221–224. https://doi.org/10.1093/jpids/piac001
Fatola, Omolayo, Amy Corneli, Brian Perry, Emily Hanlen-Rosado, Adora Nsonwu, Evangelia P. Constantine, and Amelia B. Thompson. “"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.” J Pediatric Infect Dis Soc 11, no. 5 (May 30, 2022): 221–24. https://doi.org/10.1093/jpids/piac001.
Fatola O, Corneli A, Perry B, Hanlen-Rosado E, Nsonwu A, Constantine EP, et al. "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc. 2022 May 30;11(5):221–4.
Fatola, Omolayo, et al. “"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.” J Pediatric Infect Dis Soc, vol. 11, no. 5, May 2022, pp. 221–24. Pubmed, doi:10.1093/jpids/piac001.
Fatola O, Corneli A, Perry B, Hanlen-Rosado E, Nsonwu A, Constantine EP, Thompson AB. "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc. 2022 May 30;11(5):221–224.
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
May 30, 2022
Volume
11
Issue
5
Start / End Page
221 / 224
Location
England
Related Subject Headings
- United States
- Humans
- Health Knowledge, Attitudes, Practice
- HIV Infections
- Child
- Adolescent
- AIDS Vaccines
- 3213 Paediatrics
- 3207 Medical microbiology